TransMedics Group, Inc.
corporate_fare Company Profile
TransMedics Group, Inc. (NASDAQ:TMDX) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 20 items for TMDX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-06, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 8/10, with 13 rated 8 or above. Recent SEC coverage for TMDX spans 10-Q, 8-K, DEFA14A, DEF 14A.
Recent high-impact activity:
- Shares Surge 25% as Q3 Beat and Raised 2026 Outlook Land
- TransMedics 10-Q Discloses Inventory-Related Material Weakness Alongside Record Q3 Revenue
- TransMedics Q3 Revenue Jumps 41% to $203M, Full-Year Guidance Raised to $764-$774M
- TransMedics Posts $17.1M Third-Quarter Net Income
- TransMedics Q2 Revenue Beats, But Net Income Drops on R&D Spend
Financial Snapshot
Short Interest & Short Volume
10.22 days to coverFINRA reported short interest of 8,877,506 shares in TMDX as of the October 30, 2026 settlement, a 1.2% increase from the prior period — about 10.2 days to cover at its recent average daily volume. On November 20, 2026, 55.4% of TMDX volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.